EXC vs ONCO · P/E 17, rev $24.26B vs P/E 0.0, rev $815.4K
Exelon Corporation (EXC) versus Onconetix Inc (ONCO) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported ONCO revenue for 2025-12-31 was $815.4K. Net income was -$14.0M. Revenue was down 67.7% from 2024-12-31 to 2025-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
Not investment advice. Open the EXC and ONCO stock pages for the full models.
Not investment advice.